- Home
- STRO vs PINE Comparison
STRO vs PINE Comparison
Compare STRO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | PINE |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 348.0M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | STRO | PINE |
|---|---|---|
| Price | $16.91 | $18.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $31.33 | $20.10 |
| AVG Volume (30 Days) | ★ 207.3K | 96.1K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $38,419,000.00 | ★ $60,532,000.00 |
| Revenue This Year | N/A | $18.63 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $79.61 |
| Revenue Growth | N/A | ★ 15.90 |
| 52 Week Low | $0.72 | $13.10 |
| 52 Week High | $43.85 | $21.99 |
Technical Indicators
Market Signals| Indicator | STRO | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 26.11 | 28.99 |
| Support Level | $10.34 | $17.16 |
| Resistance Level | $17.33 | $19.96 |
| Average True Range (ATR) | 0.99 | 0.38 |
| MACD | -0.24 | -0.12 |
| Stochastic Oscillator | 9.16 | 8.24 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.